Conference Proceedings

Natalizumab observational programme: assessment of long-term safety and impact on disease activity and progression of natalizumab in patients with relapsing-remitting multiple sclerosis

H Wiendl, H Butzkueven, M Trojano, D Goodin, L Kappos, D Desgrandchamps

MULTIPLE SCLEROSIS | SAGE PUBLICATIONS LTD | Published : 2009